The role of emerging therapies in the treatment of benign prostatic hyperplasia. Is it any place

Abstract

Benign prostatic hyperplasia (BPH) may lead to bladder outflow obstruction and symptoms in older men The latest developments as far as it concerns surgical treatment are focused on two principles: an office  based  procedure  without  the  need  for  general  anesthesia; and minimizing incontinence and sexual dysfunction  related  side  effects  while  retaining  satisfactory clinical efficacy. The aim of this review is to evaluate evolving minimally invasive therapies for the treatment of lower urinary tract symptoms (LUTS) caused by BPH in which ongoing clinical trials show early promise, namely, intra-prostatic injections, alcohol ablation, aquablation, the Rezum device, prostatic artery embolization (PAE), and histotripsy.